An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
Top Cited Papers
- 1 March 2003
- journal article
- Published by Elsevier in The Lancet
- Vol. 361 (9359), 726-735
- https://doi.org/10.1016/s0140-6736(03)12656-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Abacavir Substitution for Nucleoside Analogs in Patients With HIV LipoatrophyA Randomized TrialJAMA, 2002
- Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease InhibitorsJournal of Biological Chemistry, 2000
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000
- Sonographic assessment of regional fat in HIV-1-infected peopleThe Lancet, 2000
- Clinical guidelines: Developing guidelinesBMJ, 1999
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982